USSTOCK.TODAY
Pre-Market
Log in Sign up

Myriad Genetics to sell prenatal health testing business to Labcorp for $210 million

Nasdaq +1 · ·by G4L

LH Labcorp Holdings Inc
$371.83 +1.43%
View chart & analysis →
MYGN MYGN -3.04%
  1. 1Myriad Genetics Inc announced it will sell its prenatal health testing business to Labcorp Holdings Inc.
  2. 2The transaction is valued at $210 million, including cash and inventory value at closing.
  3. 3Myriad Genetics Inc shares rose 36% on Tuesday.

So what's the key point?

Myriad Genetics Inc decided to sell its prenatal testing business to Labcorp for $210 million. Following this news, Myriad Genetics Inc shares rose by 36 percent.

Source Nasdaq +1 · View original ↗

Related 3-line summaries

Myriad Genetics to sell prenatal health business to LabCorp for $210 million The Motley Fool +1 · 4d agoMyriad Genetics beats revenue and loss per share estimates Earnings Whispers +1 · 5d agoLabcorp Holdings Inc to acquire BioReference Health assets for $722 million Nasdaq +3 · Oct 15
Today's 5 AI picks, all free
Nothing hidden: past picks and how they did against the S&P 500.
See today's picks →
← Back to news